GREM1 and pulmonary arterial hypertension: Gremlin-1, an endogenous antagonist of BMP2/4/7, is markedly upregulated in PAH (Figure 1) (41, 42), which could potentially account for reduced BMPRII pathway activity in patients with normal BMPR2 expression.